Pfizer Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun '26 Jun 12, 2026	Mar '26 Mar 29, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 28, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 30, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 29, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Oct '23 Oct 1, 2023	Jul '23 Jul 2, 2023	Apr '23 Apr 2, 2023	Dec '22 Dec 31, 2022	Oct '22 Oct 2, 2022	Jul '22 Jul 3, 2022	Apr '22 Apr 3, 2022	Dec '21 Dec 31, 2021	Oct '21 Oct 3, 2021
Market Cap	149,382	154,101	141,581	135,099	137,813	143,621	150,346	164,824	158,395	157,037	162,548	187,278	206,985	230,806	287,764	245,581	292,570	291,731	331,861	240,880
Market Cap Growth	8.39%	7.30%	-5.83%	-18.03%	-12.99%	-8.54%	-7.51%	-11.99%	-23.47%	-31.96%	-43.51%	-23.74%	-29.25%	-20.88%	-13.29%	1.95%	31.52%	42.80%	61.95%	26.86%
Enterprise Value	201,032	205,784	193,079	182,122	186,678	188,712	194,514	222,845	221,020	214,924	222,020	206,963	227,815	246,992	301,117	246,386	299,811	304,396	339,490	251,338
Last Close Price	26.21	27.04	24.90	23.76	24.24	25.21	26.53	29.09	27.98	27.75	28.79	33.17	36.68	40.80	51.24	43.76	52.31	51.57	59.05	42.93
PE Ratio	20.00	20.64	18.31	13.81	12.89	18.27	18.82	39.31	-	-	77.81	18.13	9.76	8.03	9.37	8.42	10.24	11.72	15.34	12.44
Forward PE	9.22	9.13	8.54	8.46	8.59	8.55	9.91	11.18	12.28	12.54	19.25	10.94	11.49	11.95	10.82	7.65	7.78	7.17	10.64	9.82
PEG Ratio	-	-	-	-	-	3.32	1.27	1.17	1.28	1.25	-	-	-	-	-	-	-	3.91	1.00	0.87
PS Ratio	2.36	2.43	2.26	2.15	2.16	2.30	2.36	2.73	2.82	2.81	2.73	2.67	2.61	2.46	2.84	2.46	2.89	3.16	4.08	3.50
PB Ratio	1.66	1.71	1.64	1.46	1.55	1.59	1.70	1.79	1.81	1.70	1.83	1.93	2.09	2.29	3.01	2.65	3.35	3.54	4.30	3.18
P/FCF Ratio	15.75	16.25	15.60	13.02	11.08	12.80	15.29	20.03	32.93	30.76	33.91	22.90	19.41	11.42	11.05	10.51	10.29	9.18	11.11	8.08
P/OCF Ratio	12.47	12.86	12.10	10.33	9.07	10.27	11.80	14.63	19.79	18.31	18.68	15.55	14.22	9.64	9.83	9.23	9.30	8.44	10.19	7.46
EV/Sales Ratio	3.18	3.25	3.09	2.90	2.92	3.02	3.06	3.69	3.93	3.84	3.73	2.95	2.87	2.63	2.98	2.47	2.96	3.29	4.18	3.65
EV/EBITDA Ratio	7.90	14.20	26.13	11.49	10.78	13.21	18.27	20.64	87.26	45.27	31.16	11.90	7.76	6.47	7.57	6.39	7.98	9.17	11.51	8.84
EV/EBIT Ratio	10.63	26.03	242.26	19.90	17.72	25.55	53.51	57.08	-	-	265.89	18.38	9.65	7.53	8.67	7.32	9.22	10.87	13.96	10.69
EV/FCF Ratio	21.20	21.70	21.28	17.55	15.01	16.82	19.78	27.09	45.95	42.09	46.32	25.31	21.36	12.22	11.57	10.55	10.54	9.58	11.37	8.44
Debt / Equity Ratio	0.71	0.71	0.75	0.66	0.69	0.69	0.73	0.73	0.79	0.75	0.81	0.65	0.66	0.35	0.37	0.39	0.46	0.44	0.50	0.52
Debt / EBITDA Ratio	4.45	13.47	14.22	12.35	13.24	14.11	15.55	10.46	42.69	13.48	-	-	17.01	4.63	4.72	3.60	3.19	3.55	6.98	4.34
Debt / FCF Ratio	6.80	29.58	14.39	15.42	-	35.07	11.09	11.17	-	180.15	17.13	24.04	-	491.67	4.73	7.14	5.43	6.16	7.83	3.91
Net Debt / Equity Ratio	0.57	0.57	0.59	0.50	0.55	0.50	0.50	0.63	0.71	0.62	0.67	0.20	0.21	0.16	0.14	0.01	0.08	0.15	0.10	0.14
Net Debt / EBITDA Ratio	3.55	10.74	11.24	9.35	10.40	10.17	10.60	8.92	38.32	11.17	-22.60	-10.83	5.35	2.05	1.73	0.05	0.55	1.21	1.34	1.11
Net Debt / FCF Ratio	5.42	23.58	11.37	11.68	-40.46	25.29	7.56	9.53	-25.79	149.25	14.11	7.34	-9.69	218.08	1.73	0.11	0.94	2.10	1.50	1.00
Asset Turnover	0.07	0.07	0.08	0.08	0.07	0.06	0.08	0.08	0.06	0.07	0.07	0.07	0.06	0.10	0.13	0.12	0.15	0.15	0.14	0.13
Inventory Turnover	1.57	0.33	0.49	0.36	0.33	0.26	0.56	0.48	0.30	0.33	0.79	0.94	0.31	0.50	1.07	0.67	0.89	1.08	1.14	1.11
Quick Ratio	0.75	0.75	0.69	0.80	0.67	0.80	0.74	0.56	0.42	0.57	0.51	1.78	1.59	0.88	0.80	1.18	1.02	0.95	1.00	0.99
Current Ratio	1.25	1.25	1.16	1.28	1.16	1.26	1.17	1.00	0.86	1.05	0.91	2.38	2.12	1.37	1.22	1.59	1.42	1.39	1.40	1.39
Return on Equity (ROE)	2.99%	2.99%	-1.87%	3.82%	3.28%	3.25%	0.46%	4.72%	0.03%	3.23%	-3.60%	-2.51%	2.51%	6.04%	5.77%	10.24%	12.52%	10.40%	5.08%	11.55%
Return on Assets (ROA)	1.30%	1.30%	1.36%	1.66%	1.37%	1.39%	-43.88%	2.06%	0.01%	1.50%	-1.63%	-1.16%	1.13%	2.93%	3.07%	4.62%	5.41%	4.60%	2.27%	4.56%
Return on Invested Capital (ROIC)	1.42%	1.42%	1.47%	1.77%	1.43%	1.48%	-46.17%	2.39%	0.02%	1.63%	-1.73%	-1.47%	1.37%	3.32%	3.48%	5.47%	6.22%	5.24%	2.60%	5.19%
Return on Capital Employed (ROCE)	1.84%	1.84%	1.68%	1.91%	1.79%	1.58%	1.35%	2.62%	-0.06%	2.02%	-2.57%	-2.00%	1.36%	4.13%	4.13%	6.24%	8.11%	6.54%	3.12%	5.56%
Earnings Yield	5.01%	4.84%	5.46%	7.24%	7.76%	5.47%	5.31%	2.54%	-	-	1.29%	5.52%	10.25%	12.45%	10.68%	11.88%	9.77%	8.53%	6.52%	8.04%
FCF Yield	6.35%	6.15%	6.41%	7.68%	9.03%	7.81%	6.54%	4.99%	3.04%	3.25%	2.95%	4.37%	5.15%	8.75%	9.05%	9.51%	9.72%	10.89%	9.00%	12.37%
Dividend Yield	6.56%	1.59%	1.73%	1.81%	1.77%	1.70%	1.58%	1.44%	1.50%	1.51%	1.42%	1.24%	1.12%	1.00%	0.78%	0.91%	0.77%	0.78%	0.66%	0.91%
Payout Ratio	131.03%	90.99%	-148.36%	69.02%	84.02%	82.14%	580.49%	53.30%	5804.88%	76.15%	-68.71%	-97.15%	99.48%	41.55%	44.95%	26.08%	22.65%	28.60%	64.52%	26.82%
Buyback Yield / Dilution	-0.26%	-0.37%	-0.33%	-0.16%	-0.18%	-0.23%	-0.99%	-1.04%	0.30%	0.52%	1.67%	1.26%	-0.02%	0.54%	0.43%	0.12%	-0.60%	-1.70%	-1.87%	-1.63%
Total Shareholder Return	6.30%	1.22%	1.39%	1.65%	1.60%	1.48%	0.59%	0.40%	1.80%	2.03%	3.10%	2.49%	1.10%	1.54%	1.21%	1.04%	0.17%	-0.92%	-1.21%	-0.73%

SEC Filings: 10-K · 10-Q